title: Current status of MR imaging contrast agents: special report.
abstract: The first contrast agent for magnetic resonance imaging has been available for clinical use in the United States for just over 1 year. It has been widely adopted for a variety of indications with apparent safety. Several other agents are in clinical trials and are reviewed here.
authors.affiliation: Pittsburgh NMR Institute, PA 15213.
authors.forename: G L
authors.initials: GL
authors.lastname: Wolf
mesh_terms: D003287:Contrast Media; D005682:Gadolinium; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D009942:Organometallic Compounds; D004369:Pentetic Acid
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA